Effects of high-dose betahistine on intractable dizziness in patients with uncompensated unilateral vestibulopathy.

Abstract

OBJECTIVE:

In the present study, we examined the effects of high-dose betahistine on dizziness handicap inventory (DHI) scores in patients with unilateral vestibulopathy.

METHODS:

An uncontrolled, open-label, multicenter clinical trial was conducted. Fifteen patients with unilateral vestibulopathy, such as vestibular neuritis, who complained of intractable dizziness for more than three months were enrolled. Initially, all patients were orally administered betahistine at a dose of 36 mg/day for four weeks, which is the standard dose and dosing period for the treatment of dizziness in Japan. The patients were then administered betahistine at a double dose of 72 mg/day for four weeks. Six patients who became aware of the benefits of high-dose betahistine were further administered betahistine at 72 mg/day for an additional 12 weeks (a total of 16 weeks). Perceived disability due to dizziness was assessed by DHI scores.

RESULTS:

In all 15 patients, short-term administration with high-dose (72 mg/day) betahistine for four weeks, but not low-dose betahistine (36 mg/day) for four weeks significantly decreased DHI scores. In particular, in six responding patients with self-reported benefits after short-term administration with high-dose betahistine, long-term administration with high-dose betahistine for 16 weeks further significantly decreased DHI scores. However, DHI scores of the remaining nine non-responding patients were not changed after short-term administration with high-dose betahistine for four weeks.

CONCLUSION:

Short-term administration with the standard dose and dosing period of betahistine did not improve DHI scores in the enrolled patients, indicating that they were not compensated for unilateral vestibulopathy with intractable dizziness. The present findings suggest that long-term administration with high-dose betahistine facilitates vestibular compensation to improve intractable dizziness in some, but not all patients with uncompensated unilateral vestibulopathy.

• Authors: Noriaki Takeda, Go Sato, Kazunori Matsuda, Juichi Ito, Koichi Omori, Yatsuji Ito, Tadashi Kitahara, Izumi Koizuka, Hideo Shojaku, Mamoru Suzuki, Katsumi Doi, Toshihisa Murofushi, Hiroshi Yamashita
• Journal: Auris, nasus, larynx (Auris Nasus Larynx) (Sep 02 2023) ISSN: 1879-1476 [Electronic] Netherlands
• PMID: 37666746 (Publication Type: Journal Article)
• Copyright: Copyright © 2023. Published by Elsevier B.V.